2 results
Approved WMOCompleted
To determine the effective dose ED90 of Chloroprocaine for patients undergoing knee arthroscopy.
Approved WMORecruiting
The primary objective is to prospectively assess whether a sequential approach with an induction period of 12 weeks with encorafenib + binimetinib followed by an immunotherapy combination with nivolumab + ipilimumab improves Progression Free…